Press

Prevalence of Anemia among Tuberculosis Patients in Nepal: An Observational Cross-Sectional Study

Surya KC*; Sarita KC

    Tuberculosis is an infectious disease caused by mycobacterium tuberculosis. Anemia is a common co-morbidity present among people with TB, and it is associated with poor prognosis. Tuberculosis is one of the deadliest disease and a major burden on the healthcare ...


Sustaining Tuberculosis (TB) Diagnostics Cascade with the COVID-19 Pandemic Across Military Health Facilities in Nigeria

Harrison N*; Lawal I; Adamu Y; Olarinoye A; Elekwa C; Faluyi T; Okoye I; Okeji N; Chittenden L

    The impact of COVID-19 on the diagnosis and management of tuberculosis (TB) patients is evolving. The triple burden of COVID-19, Tuberculosis, and Human Immunodeficiency Virus (HIV) is one of the major global health challenges of the twenty-first century. Nigeria ranks 10th among the 22 high-burden TB countries in the world. ...


Intersecting Challenges: TB and Mental Health among Refugees in India

Ilham Zaidi*

    India has experienced a notable surge in refugee populations from neighboring states, driven by conflicts, persecution, and natural disasters. Residing in temporary settlements, these refugees face a myriad of health challenges, including a heightened susceptibility to Tuberculosis (TB) infection. ...


Contribution of Quantiferon TB Gold in Tube to the Diagnosis of Tuberculous Pleurisy: A Monocentric Prospective Study

Rachida Yahiaoui-Sidi Said; Abdelbassat Ketfi*; Fethi Meçabih; Djennette Hakem; Nadjia Ramdani; Rabah Amrane

    The diagnosis of tuberculous pleurisy remains difficult because of its paucibacillary character. Several authors have studied the usefulness of IGRAs in the early diagnosis of tuberculous pleurisy, whereas these tests are designed for the detection of latent tuberculosis infection. ...


Clinico-Demographic Profile of Drug Induced Hepatitis Patients on First Line Anti Tuberculosis Treatment in New Delhi

Rishi Kant Aharwal*; Vikram Vohra; Amit K Mehto

    Background: Drug Induced Hepatitis (DIH) is a serious adverse effect caused by Anti-Tubercular (ATT) drugs. The prevalence of DIH is much higher in developing countries owing to a higher prevalence of pre-existing chronic illnesses like acute or chronic liver disease and viral hepatitis; alcoholism; malnutrition; indiscriminate drug use; and a higher prevalence of advanced and drug-resistant TB requiring long-term treatment. ...


MedDocs Publishers

We always work towards offering the best to you. For any queries, please feel free to get in touch with us. Also you may post your valuable feedback after reading our journals, ebooks and after visiting our conferences.